The micronucleus test: a reference method for the genotoxic evaluation of cosmetic ingredients
The micronucleus test is currently one of the most reliable approaches for detecting genetic damage that could trigger cellular mutations. When cells are exposed to genotoxic stress or a potentially harmful ingredient, certain DNA fragments may fail to incorporate properly into the main nucleus during cell division. These fragments then form small separate nuclei, called micronuclei, whose presence is a warning sign about the integrity of the genetic material.
Principle and procedure of the test
The cells are first exposed to the product or ingredient being studied in a strictly controlled environment (temperature, pH, exposure time). After a division cycle, the cells are fixed and then stained using specific fluorescent markers (e.g., DAPI or anti-tubulin antibodies) that allow the micronuclei to be visualized under a high-resolution microscope. Observation is usually performed in fluorescence mode, which facilitates the distinction between the main nucleus and peripheral micronuclei. The average number of micronuclei per cell is then quantified using image analysis software, providing an accurate numerical index of the degree of genetic damage induced.
Interpretation of results
A high frequency of micronuclei indicates that the tested substance has significant genotoxic potential, while a low occurrence reflects good DNA tolerance. This criterion is particularly relevant for natural raw materials and new active ingredients derived from biotechnology, which are subject to increased scrutiny by Swiss and European authorities.
Complementarity with other genotoxicity tests
To obtain a comprehensive assessment of the genetic safety of a formulation, the micronucleus test is often combined with other recognized methods: the COMET assay (assessment of DNA breaks at the molecular level) and the TUNEL assay (detection of apoptotic DNA fragments). The combination of these three approaches covers a broad spectrum of genotoxic mechanisms, thereby strengthening the robustness of the scientific dossier presented to regulatory authorities.
Added value for the Swiss and European markets
Regulatory requirements in Switzerland, as in the European Union, mandate comprehensive documentation on the genetic safety of cosmetic ingredients. Micronucleus testing, recognized by international guidelines (notably OECD 487), provides reliable data that is accepted by the competent authorities. By including these results in the Product Information File (PIF), companies can demonstrate the compliance of their products, speed up the authorization process, and strengthen consumer confidence.
Conclusion
By commissioning micronucleus testing from a specialized laboratory, brands benefit from independent expertise, a validated methodology, and detailed reports that are ready to be incorporated into regulatory dossiers. This approach not only ensures compliance with Swiss and European requirements, but also guarantees the safety and quality of the formulations offered to end users.